je.st
news
Tag: zacks
Central Garden & Pet Co (CENT) Upgraded by Zacks Investment Research to Strong-Buy
2015-12-10 03:10:14| Chemicals - Topix.net
The firm currently has a $20.00 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 17.79% from the stock's current price.
Tags: to
research
central
garden
Zacks: J & J Snack Foods Corp (NASDAQ:JJSF) Given Average Rating of "Strong Buy" by Analysts
2015-12-09 20:01:52| Food - Topix.net
Shares of J & J Snack Foods Corp have received a consensus broker rating score of 1.00 from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Zacks: Pep Boys-Manny Moe and Jack (NYSE:PBY) Given $15.00 Consensus Target Price by Brokerages
2015-12-09 19:56:51| Auto Parts - Topix.net
Shares of Pep Boys-Manny Moe and Jack have been assigned a consensus broker rating score of 3.40 from the five analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong sell recommendation, two have issued a hold recommendation and one has assigned a strong buy recommendation to the company.
Tags: price
target
jack
consensus
OXiGENE Inc (OXGN) Stock Rating Lowered by Zacks Investment Research
2015-12-09 09:56:15| Biotech - Topix.net
According to Zacks, "OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and the development of products for use in the treatment of cancer and other major diseases. " Separately, HC Wainwright lowered their target price on shares of OXiGENE from $6.00 to $4.00 and set a "buy" rating on the stock in a research note on Friday, October 2nd.
Tags: research
rating
stock
investment
Sinovac Biotech Ltd. (SVA) Upgraded by Zacks Investment Research to "Hold"
2015-12-09 05:49:51| Biotech - Topix.net
According to Zacks, "Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, SARS, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Tags: to
research
hold
investment
Sites : [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] next »